The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study
Background The utility of heated and humidified high-flow nasal oxygen (HFNO) for severe
COVID-19-related hypoxaemic respiratory failure (HRF), particularly in settings with limited …
COVID-19-related hypoxaemic respiratory failure (HRF), particularly in settings with limited …
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial
Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO …
Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study
Purpose We aimed to describe the use of high-flow nasal oxygen (HFNO) in patients with
COVID-19 acute respiratory failure and factors associated with a shift to invasive mechanical …
COVID-19 acute respiratory failure and factors associated with a shift to invasive mechanical …
High-flow nasal oxygen for severe hypoxemia: oxygenation response and outcome in patients with COVID-19
Rationale: The “Berlin definition” of acute respiratory distress syndrome (ARDS) does not
allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several …
allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several …
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection
A Vianello, G Arcaro, B Molena, C Turato, A Sukthi… - Thorax, 2020 - thorax.bmj.com
This observational study aims to assess the outcome and safety of O2-therapy by high-flow
nasal cannula (HFNC) in 28 consecutive patients with severe hypoxemic acute respiratory …
nasal cannula (HFNC) in 28 consecutive patients with severe hypoxemic acute respiratory …
High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study
N Bonnet, O Martin, M Boubaya, V Levy, N Ebstein… - Annals of intensive …, 2021 - Springer
Background The efficacy of high flow nasal canula oxygen therapy (HFNO) to prevent
invasive mechanical ventilation (IMV) is not well established in severe coronavirus disease …
invasive mechanical ventilation (IMV) is not well established in severe coronavirus disease …
[HTML][HTML] High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU
T Guy, A Créac'Hcadec, C Ricordel… - European …, 2020 - Eur Respiratory Soc
High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ Early …
European Respiratory Society Skip to main content Main menu Home Current issue ERJ Early …
High-flow nasal oxygen in coronavirus disease 2019 patients with acute hypoxemic respiratory failure: a multicenter, retrospective cohort study
J Xia, Y Zhang, L Ni, L Chen, C Zhou, C Gao… - Critical care …, 2020 - journals.lww.com
Objectives: An ongoing outbreak of coronavirus disease 2019 is spreading globally. Acute
hypoxemic respiratory failure is the most common complication of coronavirus disease 2019 …
hypoxemic respiratory failure is the most common complication of coronavirus disease 2019 …
Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized …
Importance The benefit of high-flow nasal cannula oxygen (high-flow oxygen) in terms of
intubation and mortality in patients with respiratory failure due to COVID-19 is controversial …
intubation and mortality in patients with respiratory failure due to COVID-19 is controversial …
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study
G Procopio, A Cancelliere… - Therapeutic …, 2020 - journals.sagepub.com
The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …
相关搜索
- sars cov oxygen therapy
- covid 19 nasal oxygen
- severe hypoxemia nasal oxygen
- severe covid oxygen therapy
- covid 19 severe hypoxemia
- outcome in patients nasal oxygen
- covid 19 respiratory failure
- mild hypoxaemia nasal oxygen
- covid 19 outcome in patients
- oxygenation response nasal oxygen
- efficient treatment nasal oxygen
- severe covid clinical recovery
- coronavirus disease nasal oxygen
- covid 19 oxygenation response
- covid 19 cannula oxygen
- covid 19 oxygen therapy